Similar articles

• The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma.

  Coward RA, Delamore IW, Mallick NP, Robinson EL. Coward RA, et al. Clin Sci (Lond). 1984 Feb;66(2):229-32. doi: 10.1042/cs0660229. Clin Sci (Lond). 1984. PMID: 6420108
• Immunoglobulin light chain nephropathies.

  Sturgill BC, Tucker FL, Bolton WK. Sturgill BC, et al. Pathol Annu. 1987;22 Pt 2:133-50. Pathol Annu. 1987. PMID: 3120137 Review.
• [Free immunoglobulin L chains].

  Numata Y. Numata Y. Rinsho Byori. 1983 May;31(5):489-95. Rinsho Byori. 1983. PMID: 6415322 Review. Japanese. No abstract available.
• Renal failure as the presenting feature of light chain myeloma of kappa type.

  Raina V, Veluchamy K, Kumar R, Malaviya AN. Raina V, et al. J Assoc Physicians India. 1982 Sep;30(9):636-8. J Assoc Physicians India. 1982. PMID: 6820955 No abstract available.
• Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.

  Pasquali S, Zucchelli P, Casanova S, Cagnoli L, Confalonieri R, Pozzi C, Banfi G, Lupo A, Bertani T. Pasquali S, et al. Clin Nephrol. 1987 May;27(5):222-8. Clin Nephrol. 1987. PMID: 3109793